Mei Bai
Researcher
Also affiliated: University of Massachusetts Dartmouth (2025); University of Maryland, Baltimore (2015); Central South University (2012–2017); Minzu University of China (2020); Deakin University (2024); Xizang Minzu University (2018–2021); Shanghai Jiao Tong University (2019–2023); University of Missouri–St. Louis (2018); University of Arkansas Medical Center (2025); Yale University (2013–2017); Mudanjiang Medical University (2012); JiangSu Armed Police General Hospital (2024–2025); Nanjing Drum Tower Hospital (2022–2025); Jiangxi Chest Hospital (2024); Hellenic Cooperative Oncology Group (2012); Beijing Municipal Ecological and Environmental Monitoring Center (2024); Second Hospital of Tianjin Medical University (2012–2016); Tibet Autonomous Region People's Hospital (2018–2019); Surgical Specialties (United States) (2025); Association for Language Learning (2013); Shanghai Sixth People's Hospital (2012–2023); Second Xiangya Hospital of Central South University (2012–2017); Children's Hospital of Fudan University (2025); Tianjin Medical University (2012–2016); Nanjing University (2025)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mei Bai's research focuses on investigating disease mechanisms and potential therapeutic interventions, particularly in the context of liver injury, intestinal fibrosis, and cancer progression. Bai has published work exploring the direct inhibition of GSDMD by PEITC to reduce hepatocyte pyroptosis and alleviate acute liver injury in mice, as well as the role of natural compound fraxinellone in ameliorating intestinal fibrosis by intervening with HSP47-collagen interaction. Further investigations include the STAT3-mediated activation of lncRNA NR2F1‐AS1 in melanoma progression and the association of Fc receptor-like variants with rheumatoid arthritis risk in the Chinese Han population. Bai also contributed to a systematic review on the psychological response to advanced cancer diagnoses. Scholarship metrics include an h-index of 19, with 76 total publications and 1,393 total citations.
Metrics
- h-index: 19
- Publications: 76
- Citations: 1,408
Selected Publications
-
Psychological Adaptation to Newly Diagnosed Advanced Cancer (2025)
-
Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial (2025)
-
Psychological Response to the Diagnosis of Advanced Cancer: A Systematic Review (2021)
Collaboration Network
Top Collaborators
- Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial
- Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial
- Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial
- Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trial
- Psychological Adaptation to Newly Diagnosed Advanced Cancer
Similar Researchers
Based on overlapping research topics